Table 2 O. volvulus nodule, skin Mf prevalence, and density after several rounds of ivermectin mass drug administration
State | Study village | Baseline nodule prevalencea,b | Number of ivermectin MDA rounds | Number of participants | Nodule prevalence (95% CI) | Skin microfilaria prevalence (95% CI) | Geometric mean Mf/mg |
|---|---|---|---|---|---|---|---|
Enugu | |||||||
Amokwe | 42.0 | 26 | 45 | 55.6 (44.2, 60.5) | 51.1 (37.0, 65.0) | 2.2 | |
Eziobodo | 54.0 | 26 | 45 | 51.1 (37.0, 65.0) | 33.3 (21.4, 48.0) | 3.1 | |
Obinagu/Eziama | 58.0 | 26 | 50 | 42.0 ( 29.4, 55.8) | 32.0 (20.8, 45.9) | 3.0 | |
Ugwuorie | 42.0 | 26 | 30 | 46.7 (30.3, 63.8) | 36.7 (21.9, 54.6) | 1.0 | |
Umuezemanna | 44.0 | 26 | 15 | 66.7, 41.5, 84.8) | 46.7 (24.9, 69.8) | 1.6 | |
Umunnakwe | 44.0 | 26 | 40 | 62.5 (46.9, 75.6) | 50.0 (35.2, 64.8) | 2.2 | |
Ogun | |||||||
Abule Aje | 4.8 | 14 | 41 | 0 (0.0, 10.5) | 4.9 (0.6, 17.2) | 0.3 | |
Abule Peter | 4.8 | 14 | 43 | 0 (0.0, 10.0) | 2.3 (0.0, 13.4) | 0.2 | |
Adeaga | 16.0 | 11 | 32 | 3.1 (0.0, 17.4 | 28.1 (15.5, 45.6) | 0.4 | |
Ibara Afon | 30.0 | 14 | 48 | 4.2 (0.4, 14.9) | 6.3 (1.6, 17.6) | 0.3 | |
Ibaro | 12.0 | 14 | 42 | 9.5 (0.3, 22.8) | 28.6 (17.1, 43.7) | 3.4 | |
Idode | 6.0 | 0 | 50 | 4.0 (0.4, 14.4) | 20.0 (11.1, 33.1) | 0.3 | |
Imomo | 6.0 | 0 | 40 | 25.0 (13.1, 42.4) | 15.0 (6.8, 29.6) | 0.3 | |
Isara | 22.0 | 3 | 32 | 10.7 (3.0, 28.2) | 9.4 (2.6, 25.2) | 0.3 | |
Olokemeji | 16.0 | 11 | 28 | 10.9 (4.4, 23.6) | 21.4 (9.9, 40.0) | 0.4 | |
Olowo | 16.0 | 11 | 46 | 3.7 (2.2, 6.1) | 0.0 (0.0, 9.4) | 0.0 |